![Andrew Kelly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Kelly
Corporate Officer/Principal presso The University of Newcastle
Posizioni attive di Andrew Kelly
Società | Posizione | Inizio | Fine |
---|---|---|---|
The University of Newcastle | Corporate Officer/Principal | - | - |
Storia della carriera di Andrew Kelly
Precedenti posizioni note di Andrew Kelly
Società | Posizione | Inizio | Fine |
---|---|---|---|
Biotecnol-Serviços e Desenvolvimento SA
![]() Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Direttore Tecnico/Scientifico/R&S | 27/10/2009 | - |
Formazione di Andrew Kelly
King's College London | Doctorate Degree |
Statistiche
Distribuzione geografica
Portogallo | 2 |
Regno Unito | 2 |
Australia | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Settori
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Biotecnol-Serviços e Desenvolvimento SA
![]() Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Commercial Services |
- Borsa valori
- Insiders
- Andrew Kelly
- Esperienza